… -targeting ligands labeled with radionuclides have been evaluated in several preclinical and
clinical … are three types of radiation that can be used for targeted radionuclide therapy: β − -…

… Radionuclide therapy has been employed frequently in the past several decades for … ,
curative therapy, and pain management applications [1]. Targeted radionuclide therapy (TRT) is …

… of radionuclide therapy aimed at other targets and tumor types. … target that is currently
being used in clinical practice is the SSTR, and this review will focus on PRRT for this target…

… , its clinical merits in current treatment and future perspectives. We will highlight different
radionuclides … peptide-conjugates that hold these radionuclides. We will zoom in on the latest …

… In contrast to external high energy photon or proton therapy, targeted radionuclide therapy
(TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all …

… for low LET radiation. Radiobiological characterization of targeted radionuclide therapy has
… This opens an opportunity for α radiation therapy labeled to PSMA ligands. Kratochwil et al. …

… Recently, several studies demonstrated the efficacy of systemic therapy with peptide
receptor radionuclide therapy in patients with advanced metastatic neuroendocrine neoplasms, …

… most patients with HCC have HCC from viral or alcoholic hepatitis, BNCT is a cellular-level
radiation therapy that protects normal liver cells from irradiation and ensures treatment safety. …

… Multiple studies have shown that targeted radionuclide therapy is successful. With radioactive
iodine, well-differentiated iodine-avid thyroid cancer was transformed from a disease with …

… The field of radiotheranostics, which is the focus of this Review, combines molecular imaging
(primarily PET and SPECT) with targeted radionuclide therapy, which involves the use of …